
# Summary


|number| Article                                      | Function            | Author          &         Year     | Citations| Code                                               | Data                                          | Model                     |Status|
|----------------------------------------------|---------------------------------------------------------------------------------|-----------------|------|--|----------------------------------------------------|------------------------------------------------|---------------------------|--|
|1| ~~[DNAm biomarkers for pan-cancer diagnosis](https://www.tandfonline.com/doi/full/10.1080/15592294.2019.1568178?scroll=top&needAccess=true)~~ | Cancer Predictor     | Wubin DingCenter   2019 |71| Unpublished                                        | Unpublished                                    | OneVsAll       |
|2| [DNAm signature differentiates pancreatic cancer from chronic pancreatitis](https://gut.bmj.com/content/72/12/2344) | Pancreatic Cancer Predictor     | Yenan Wu   2019 |11| Unpublished                                        | [arrayexpress](https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-3855?query=E-MTAB-3855)                                    | random-forest machine-learning approach       | [ ] |
|3| [lung cancer](https://link.springer.com/article/10.1186/s13148-021-01163-w#Abs1)|lung cancer| | | | |Logistic Regression | [ ] |
|4| [DNA methylation measurements in prostate tissues](https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3252-2) | Prostate Cancer Predictor       | Marie K. Kirby    2017 |39| Unpublished                                        | [GSE76938](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76938) | Linear Mixed Model         | [x] |
|5| [Epigenetic prediction of complex traits and death](https://genomebiology.biomedcentral.com/articles/10.1186/s13059-018-1514-1) | Common Traits Predictor         | Daniel L. McCartney  2018 | 96|Unpublished                                        | Generation Scotland (Need approval from GS Access Committee) | Logistic Regression       | [ ] |
|6| [DNA methylation as a predictor of fetal alcohol spectrum disorder](https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-018-0439-6) | Predictor of Fetal Alcohol Spectrum Disorder | Alexandre A. Lussier  2018 |37| Unpublished                                        | GSE50759                                       | Stochastic Gradient Boosting | [ ] |
|7| [Epigenetic prediction of coronary heart disease](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190549#sec002)   | predictor of coronary heart disease  | Meeshanthini V. Dogan   2018 |75| unpublished                                          | [dbGAP](https://dbgap.ncbi.nlm.nih.gov)          | Random Forest classification model  | [ ] |
|8| [EWAS of metabolic syndrome and its components](https://www.nature.com/articles/s41598-020-77506-z#Abs1) | Predictor of metabolic syndrome  | Marja-Liisa Nuotio (2020)  | 25 | Unpublished                                          | NFBC1966 (needing request and permission from THL Biobank and University of Oulu) | Random Forest classification model  | [ ] |
|9| [EWAS of Incident Type 2 Diabetes in a British Population](https://diabetesjournals.org/diabetes/article/68/12/2315/39835/Epigenome-Wide-Association-Study-of-Incident-Type) | Predictor of Type 2 diabetes  | Alexia Cardona (2019) | 44 | Unpublished                                          | EPIC-Norfolk (needing request and permission)  | Logistic regression model  | [ ] |
|10| [Epigenetic Signatures of Cigarette Smoking](https://www.ahajournals.org/doi/10.1161/CIRCGENETICS.116.001506) | Smoking Habits Examination  | Roby Joehanes  2016 | 508 | Unpublished                                          | 16 cohorts of the Cohorts for Heart and Aging Research in Genetic Epidemiology Consortium  | Linear regression | [ ] |
|11| [EWAS of Cardiovascular Disease Risk and Interactions](https://www.ahajournals.org/doi/10.1161/JAHA.119.015299) | Cardiovascular Disease predictor  | Kenneth Westerman (2020) | 21 | [GitHub](https://github.com/kwesterman/meth_cvd)  | LBC 1936  | Study-specific regression models: CSL cross-study learner  | [ ] |
|12| [potential blood biomarkers for Parkinson’s disease](https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-019-0621-5) | Parkinson Disease predictor  | Changliang Wang (2020) | 37 | Unpublished                                          | [DNA methylation data](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111629 )  | Linear model  | [ ] |
|13| ~~[predict Alzheimer’s disease progression using temporal DNA methylation data in peripheral blood](https://www.sciencedirect.com/science/article/pii/S2001037022004639?via%3Dihub#s0010)~~ | Alzheimer’s disease predictor  | Li Chen (2022) | 2 | [Published](https://github.com/lichen-lab/MTAE)  | ADNI public data  | Unsupervised dimensionality reduction model  | [ ] |
|14| [Evaluation and prediction of late-onset Alzheimer’s disease](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0248375) | Another Alzheimer’s disease predictor  | Ray O. Bahado-Singh (2021)  | 19 | Unpublished                                          | Unpublished  | DL model  | [ ] |
|15| [DNA methylation signature predict colorectal cancer susceptibility](https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-07194-5#Sec2) | Colorectal Cancer predictor  | Justina Ucheojor Onwuka  2020 | 11 | Unpublished                                          | GSE51032  |MRS + logistic regression | [ ] |
|16| [colorectal cancer susceptibility](https://www.science.org/doi/10.1126/scitranslmed.aax7533) | Colorectal Cancer predictor  | HUIYAN LUO  2020 | 11 | Unpublished                                          | Unpublished  |cd-score + logistic regression | [ ] |
|17| [DNA methylation age of blood predicts future onset of lung cancer in the women's health initiative](https://www.aging-us.com/article/100809/text) | Female Lung Cancer predictor  | Morgan E. Levine  2015 | 11 | Unpublished                                          | Women's Health Initiative  | Logistic regression models and ran Cox models | [ ] |
|18| [DNA methylation profiles for predicting breast cancer risk](https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.12594) | Breast Cancer predictor  | Zhong Guan  2019 | 9 | Unpublished                                          | Unpublished  | Multivariable logistic regression | [ ] |
|19| [EWAS Indicates Hypomethylation of MTRNR2L8 in Large-Artery Atherosclerosis Stroke](https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.023436) | Atherosclerosis Stroke predictor  | Yupei Shen  2019 | 27 | Unpublished                                          | Unpublished  | Linear regression | [ ] |
|20| [DNA Epigenomic Prediction of Cerebral Palsy](https://www.mdpi.com/1422-0067/20/9/2075) | Cerebral Palsy predictor  | Ray O. Bahado-Singh  2019 | 15 | Unpublished                                          | Unpublished  | Univariate logistic regression | [ ] |
|21| [DNA methylation signatures of dementia risk](https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/dad2.12078) | Dementia predictor  | Rosie M. Walker 2020 | 3 | Unpublished                                          | Unpublished  | Linear regression model | [ ] |
|22| ~~[CancerLocator](https://genomebiology.biomedcentral.com/articles/10.1186/s13059-017-1191-5?site=n_detail_link)~~ | Multiple Cancer Predictor        | Shuli Kang        2017 |168| [GitHub - JAVA](https://github.com/jasminezhoulab/CancerLocator/tree/v1.0.1) | Simulated data generated by themselves          | Probability Model         | [ ] |
|23| [tissue predictor](https://doi.org/10.1093/nar/gkt1380) | tissue predictor    |Baoshan Ma      2014 |101| unpublished | [ECACC](http://www.hpacultures.org.uk/collections/ecacc.jsp)   | Linear prediction model&Support vector machine&Cross-validation        | [ ] |



# Disease predictor

## ~~18 cancer predictor~~

**This paper is dismissed for lack of suitable test dataset (They use OneVsAll methods that incorporate all the disease together, and it is for us to find a single test dataset that includes so many diseases.**


| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | pancreatic cancer predictor  | 
|  source  | ~~[Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis](https://www.tandfonline.com/doi/full/10.1080/15592294.2019.1568178?scroll=top&needAccess=true)~~  Wubin DingCenter(2019) | 
| code   | unpublished   | 
| data   | unpublished  | 
| model  | logistic regression  |

logistic regression based on the selected seven features was used to construct the tumor-normal diagnostic model. OneVsRestClassifier with estimator of logistic regression was employed to train the tumor specific multiclass classifier. They randomly split the full dataset into training and test sets with 4:1 ratio in both tumor-normal diagnostic model and tissue-specific classifier.



## pancreatic cancer predictor


| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | pancreatic cancer predictor  | 
|  source  | [DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma](https://gut.bmj.com/content/72/12/2344)  Yenan Wu(2019) | 
| code   | unpublished   | 
| data   | unpublished  | 
| model  | logistic regression  |
>For all datasets, missing feature values were substituted by the overall feature median.

>In all lists, correlated features were removed by applying a threshold on the calculated Pearson’s correlation coefficients. For DNA-methylation, a threshold of 0.9 was used

>10 equal folds  random-forest models

>accuracy, sensitivity, specificity and the area under the curve (AUC) were calculated.For final model scores, the metrics were averaged across all folds

>The trained models for the differentiation of PDAC and N exhibited cross-validated AUCs between 0.85 and 0.98, when features of the respective dataset were added consecutively. A predictive model based on DNA-methylation showed the highest AUC value—0.980—with the lowest number of features, namely cg02964172 (gene GCNT2, gene body) and cg17184704 (intergenic, chr. 10: 11727286).

Their other focus are distinguishing between pancreatic cancer and pancreatitis, which has been overlooked.

## prostate cancer predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | prostate cancer predictor  | 
|  source  | [Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns](https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3252-2)  Marie K. Kirby(2017) | 
| code   | unpublished   | 
| data   | [GSE76938](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76938)  | 
| model  | linear mixed model  |

They calculated the methylation beta score as: b = IntensityMethylated/(IntensityMethylated + IntensityUnmethylated) and converted data points that were not significant above background intensity to NAs.  CpGs having greater than 10% missing values prior to normalization were removed. CpGs with a standard deviation of less than 1% across samples were removed. Linear mixed model analysis of the methylation data was performed with patient as a random effect, and age and ethnicity as fixed effects.The p-values were adjusted using the Benjamini and Hochberg method

our AUC（0.96）is similar to their AUC（0.97）

## common traits predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | common traits predictor  | 
| source   | [Epigenetic prediction of complex traits and death](https://genomebiology.biomedcentral.com/articles/10.1186/s13059-018-1514-1) Daniel L. McCartney（2018）| 
| code   |unpublished   | 
| data   | Generation Scotland（need approval from GS Access Committee）  | 
| model  | LASSO regression&linear mixed model  |

check if GSE69914, GSE76938, GSE48684, GSE73549, GSE65820, GSE66836, GSE89852, GSE58999 and GSE38240 is usable



They model the traits of interest as the outcomes and the CpGs as the predictors and train optimized predictors using penalized regression methods, then apply these predictors to approximately 900 individuals to determine: 

(1) the proportion of variance the DNAm predictors explain in the outcomes;

(2) the extent to which these proportions are independent from the contribution of genetics; 

(3) the accuracy with which the DNAm predictors can identify obese individuals, college-educated individuals, heavy drinkers, high cholesterol levels, and current smokers if provided with a random DNA sample from the population; 

(4) the extent to which they can predict health outcomes, such as mortality, and if they do so independently from the phenotypic measure.

Methylation preparation:
>Filtering for outliers, sex mismatches, non-blood samples, poorly detected probes, and samples was performed(Additional file 4). CpGs with missing values, non-autosomal and non-CpG sites, and any sites not present on the Illumina 450 k array was removed.

LASSO regression in Generation Scotland:
>Penalized regression models were run using the glmnet library in R. Tenfold cross-validation was applied and the mixing parameter (alpha) was set to 1 to apply a LASSO penalty. Coefficients for the model with the lambda value corresponding to the minimum mean cross-validated error were extracted and applied to the corresponding CpGs in an out of sample prediction cohort to create the DNAm predictors.

Prediction analysis in the Lothian Birth Cohort 1936:
>Area under the curve (AUC) estimates were estimated for binary categorizations of traits. Ordinal logistic regression was used for the categorical smoking variable (never, ex, current smoker). ROC curves were developed for smoking status, obesity, high/low alcohol consumption, college education and cholesterol variables, and AUC estimates were estimated for binary categorizations of these variables using the pROC library in R.Sex was included as a covariate in all models. Correction for multiple testing was applied using the Bonferroni method.

DNAm predictors classify phenotype extremes
>652 controls and 242 cases for obesity, 745 light-to-moderate drinkers and 150 heavy drinkers, 418 non-smokers and 102 current smokers, 229 and 666 individuals with > 11 and ≤ 11 years of full-time education, 531 and 354 individuals with high and low total cholesterol,  89 and 723 individuals with high and low HDL cholesterol,  637 and 175 individuals with high and low LDL with remnant cholesterol, 307 and 502 with high and low total:HDL cholesterol ratios.

Results for comparison:

| Trait                                      | AUC   | 95% Confidence Interval (CI)       |
|--------------------------------------------|-------|-------------------------------------|
| Current Smokers vs. non-smokers            | 0.98  | 0.97–1.00 (Fig. 2)                  |
| Obesity vs. Non-obesity                    | 0.67  | 0.63–0.71                           |
| High HDL vs. Low HDL                       | 0.70  | 0.64–0.75                           |
| Light-to-Moderate Drinkers vs. Heavy Drinkers| 0.73  | 0.69–0.78                           |
| > 11 vs. ≤ 11Years of Full-time Education    | 0.59  | 0.55–0.63 (Fig. 2)                  |
| Total Cholesterol High vs. Low              | 0.61  | 0.57–0.64                           |
| High LDL vs. Low LDL                        | 0.53  | 0.48–0.58                           |
| TC:HDL ratio High vs. Low               | 0.61  | 0.57–0.65                           |


## fetal alcohol spectrum disorder predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | predictor of fetal alcohol spectrum disorder  | 
| source   | [DNA methylation as a predictor of fetal alcohol spectrum disorder](https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-018-0439-6) Alexandre A. Lussier（2018）| 
| code   |unpublished   | 
| data   | GSE50759  | 
| model  |stochastic gradient boosting  |

filter:(1) probes on X and Y chromosomes (n = 11,648), (2) SNP probes (n = 65), (3) probes with bead count < 3 in 10% of samples (n = 726), (4) probes with 10% of samples with a detection p value > 0.01 (n = 11,864), and (5) probes with a polymorphic CpG and non-specific probes (N = 19,337 SNP-CpG and 10,484 non-specific probes)
linear modeling was performed on the 648 differentially methylated probes identified in the initial NDN study and found in the present dataset using the limma package in R and a model that included clinical status and all identified SVs as covariates.Benjamini-Hochberg method was used.

## coronary heart disease predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | predictor of coronary heart disease  | 
| source   | [Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190549#sec002) Meeshanthini V. Dogan（2018）| 
| code   |unpublished   | 
| data   | [dbGAP] (https://dbgap.ncbi.nlm.nih.gov)  | 
| model  |Random Forest classification model  |

To reduce the number of DNA methylation loci:
first, the correlation was calculated between the 472,822 CpG sites and CHD status. CpG sites were retained if the point bi-serial correlation with CHD was at least 0.1. A total of 138,815 CpG sites remained. 
Subsequently, Pearson correlation between those 138,815 sites was calculated. If the Pearson correlation between two loci was at least 0.8, the loci with a smaller point bi-serial correlation (i.e. less correlated with CHD) was discarded. In the end, 107,799 DNA methylation loci (~23%) remained for model training
 A grid search using GridSearchCV was employed to perform 10-fold cross-validation hyper-parameter tuning (maximum features: auto, minimum samples for each split: 2–10, information gain criterion: entropy or gini, maximum tree depth: 500–2500, number of trees: 10000–30000) of the models.All eight final tuned models were saved for testing on the test dataset where majority voting was used to ensemble the votes of these models.

 ## metabolic syndrome predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | predictor of coronary heart disease  | 
| source   | [An epigenome-wide association study of metabolic syndrome and its components](https://www.nature.com/articles/s41598-020-77506-z#Abs1) Marja-Liisa Nuotio（2020）| 
|citations|25|
| code   |unpublished   | 
| data   | NFBC1966 (needing request and permission from THL Biobank and University of Oulu | 
| model  |Random Forest classification model  |

using regression analysis fitting generalised linear models.Analyses were adjusted for age, sex, smoking status (defined either as current or never/ex-smokers), alcohol consumption (grams/week), cell subtype proportion, study- specific technical covariates (described in detail in Supplementary material), and the first five genetic principal components of the data to control for potential population substructure.

 ## Type 2 diabetes predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | predictor of Type 2 diabetes  | 
| source   | [Epigenome-Wide Association Study of Incident Type 2 Diabetes in a British Population: EPIC-Norfolk Study](https://diabetesjournals.org/diabetes/article/68/12/2315/39835/Epigenome-Wide-Association-Study-of-Incident-Type) Alexia Cardona（2019）| 
|citations|44|
| code   |unpublished   | 
| data   | EPIC-Norfolk (needing request and permission  | 
| model  |logistic regression model  |

 ## Cardiovascular Disease predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | Cardiovascular Disease predictor | 
| source   | [Epigenomic Assessment of Cardiovascular Disease Risk and Interactions With Traditional Risk Metrics](https://www.ahajournals.org/doi/10.1161/JAHA.119.015299) Kenneth Westerman（2020）| 
|citations|21|
| code   |[github](https://github.com/kwest​erman/​meth_cvd)   | 
| data   | LBC 1936  | 
| model  |study‐specific regression models:CSL cross‐study learner  |

 ## Parkinson Disease predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | Parkinson  Disease predictor | 
| source   | [Identification of potential blood biomarkers for Parkinson’s disease by gene expression and DNA methylation data integration analysis](https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-019-0621-5) Changliang Wang（2020）| 
|citations|37|
| code   |unpublished   | 
| data   | [DNA methylation data](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111629 )  | 
| model  | linear model  |


 ## ~~Alzheimer’s disease predictor~~

**They observe three types of AD diagnosis: cognitive normal (CN), mild cognitive impairment (MCI) and dementia (AD).But they didn't use baseline data to predict disease outcomes; instead, they used four-year, four-timepoint longitudinal data to predict four outcomes: CN-to-CN (n = 147), CN-to-MCI (n = 44), MCI-to-MCI (n = 147), and MCI-to-AD (n = 111).
Maybe not suitable for our research.**

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |Alzheimer’s diseasepredictor | 
| source   | [Multi-task deep autoencoder to predict Alzheimer’s disease progression using temporal DNA methylation data in peripheral blood ](https://www.sciencedirect.com/science/article/pii/S2001037022004639?via%3Dihub#s0010)Li Chen（2022）| 
|citations|2|
| code   |[published](https://github.com/lichen-lab/MTAE)   | 
| data   | ADNI public data  | 
| model  | unsupervised dimensionality reduction model  |



 ## another Alzheimer’s disease predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |Alzheimer’s diseasepredictor | 
| source   | [Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer’s disease](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0248375)Ray O. Bahado-Singh（2021）| 
|citations|19|
| code   |unpublished | 
| data   | unpublished  | 
| model  | DL model  |

 ## dementia predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |dementia predictor | 
| source   | [Epigenome-wide analyses identify DNA methylation signatures of dementia risk](https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/dad2.12078)Rosie M. Walker（2020）| 
|citations|3|
| code   |unpublished | 
| data   | unpublished  | 
| model  | linear regression model |

 ## colorectal cancer predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |colorectal cancer predictor | 
| source   | [A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility](https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-07194-5#Sec2)Justina Ucheojor Onwuka（2020）| 
|citations|11|
| code   |unpublished | 
| data   | GSE51032  | 
| model  | stepwise logistic regression |
>extracted the data containing the DNA methylation status of 485,512 CpG sites in the 166 participants who had developed primary colorectal cancer and the 424 matched cancer-free participants.
>normalization
>probes with detection P-value > 0.01 in at least one sample were filtered out
>Differentially methylated markers associated with CRC risk were screened on the training dataset using LASSO selection and stepwise logistic regression analysis. sixteen-CpG panel overlapping between the two methods were selected to calculate a methylation risk score (MRS)
>The MRS (range, − 5.59 to 4.35) was significantly higher for CRC subjects than in healthy normal subjects (P <  0.000), with a median MRS of 1.68 (IQR, 1.43) in CRC subjects and − 0.430 (IQR, 2.89) in healthy normal subjects. The MRS was associated with a 2.68-fold increased risk of CRC (OR = 2.68, 95% CI: 2.13, 3.38, P <  0.0001). The MRS showed a good predictive ability for discriminating between CRC and healthy normal subjects (AUC, 0.85; 95% CI: 0.81, 0.89).
>Similar to the training dataset, the MRS showed a good predictive ability for discriminating between CRC and healthy normal subjects (AUC, 0.82; 95% C: 0.76, 0.88) .

 ## female lung cancer predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |female lung cancer | 
| source   | [DNA methylation age of blood predicts future onset of lung cancer in the women's health initiative](https://www.aging-us.com/article/100809/text)Morgan E. Levine（2015）| 
|citations|11|
| code   |unpublished | 
| data   |Women's Health Initiative | 
| model  | logistic regression models and ran Cox models |

 ## breast cancer predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |breast cancer predictor | 
| source   | [Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk](https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.12594)Zhong Guan（2019）| 
|citations|9|
| code   |unpublished | 
| data   |unpublished  | 
| model  | multivariable logistic regression |

 ## Atherosclerosis Stroke cancer predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |Atherosclerosis Stroke predictor | 
| source   | [Epigenome-Wide Association Study Indicates Hypomethylation of MTRNR2L8 in Large-Artery Atherosclerosis Stroke](https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.023436)Yupei Shen（2019）| 
|citations|27|
| code   |unpublished | 
| data   |unpublished  | 
| model  | linear regression |

 ## Cerebral Palsy predictor

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |Cerebral Palsy predictor | 
| source   | [Deep Learning/Artificial Intelligence and Blood-Based DNA Epigenomic Prediction of Cerebral Palsy](https://www.mdpi.com/1422-0067/20/9/2075)Ray O. Bahado-Singh（2019）| 
|citations|15|
| code   |unpublished | 
| data   |unpublished  | 
| model  | univariate logistic regression |


 ## smoking habits examination

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |smoking habits examination | 
| source   | [Epigenetic Signatures of Cigarette Smoking](https://www.ahajournals.org/doi/10.1161/CIRCGENETICS.116.001506)Roby Joehanes（2016）| 
|citations|508|
| code   |unpublished | 
| data   |16 cohorts of the Cohorts for Heart and Aging Research in Genetic Epidemiology Consortium  | 
| model  |linear regression |



## ~~Cancerlocator~~

**cell free dna data is not suitable for our project**

| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   | multiple cancer predictor  | 
| source   | [CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA](https://genomebiology.biomedcentral.com/articles/10.1186/s13059-017-1191-5?site=n_detail_link#Sec7) Shuli Kang(2017)   | 
| code   | [github-JAVA](https://github.com/jasminezhoulab/CancerLocator/tree/v1.0.1)    | 
| data   | simulated data generated by themselves  | 
| model  | probability model  | 


# Tissue predictor


| Tags                                      | Content   |
|--------------------------------------------|-------|
| function   |tissue predictor  | 
| source   | [Predicting DNA methylation level across human tissues](https://doi.org/10.1093/nar/gkt1380) Baoshan Ma(2014)   | 
| code   | unpublished   | 
| data   | [ECACC](http://www.hpacultures.org.uk/collections/ecacc.jsp)  | 
| model  | Linear prediction model&Support vector machine&Cross-validation| 



normalization:
>HumanMethylation450 array, we used the pipeline developed by Touleimat and Tost (21). Individual data points with detection P > 0.01 or number of beads <3 were treated as missing data. Samples with >20% missing probes were treated as missing data. 
linear model was developed.
SVM model is constructed in a similar manner as the linear regression method. For a given CpG site j, we used xij and yij as the training data set to build an SVM model.[their R package](http://www.hsph.harvard.edu/liming-liang/cross-tissue-methylation/).

They did not disclose their training data, but they used publicly available GSE data as test data and provided model performance parameters. Therefore, I am currently training on our EWAS data and will also try the GSE public data they used
>In the independent data set of six individuals and 24 LCL T cell pairs, the correlation R2 between predicted value and T cell methylation was 0.95 for both SVM and LM models (average across 144 LCL-T cell pairs) compared with 0.92 for LCL-T cell correlation (Supplementary Figure S17). After removing CpG sites with minimum methylation β values > 0.9 or maximum β values < 0.1 among all subjects in both LCL and T cells, our prediction model increased the overall R2 from 0.88 to 0.92. When the cut-points for minimum and maximum β values were changed to 0.8 and 0.2, respectively, the overall correlation R2 increased from 0.80 to 0.87. The magnitude of improvement was smaller than the cross-validation estimate in our 39 samples (Supplementary Figure S17). This is likely because the target tissue in the training data set is PBLs, whereas the target tissue in testing data set is T cells. The significant improvement, especially for LCL-T cell pairs with lower correlation (Supplementary Figure S17), suggests that the prediction model built in a training data set is applicable to future studies and improves the utility of surrogate tissues.

# Project Progress and Plan

## Overview
Reproduce the "Tissue Predictor" and "Disease Predictor" models. This document will track the progress and detailed plan of the project.

## Progress Overview

## Task List
### 1. Literature Review
- [ ] Read papers and select suitable ones (high quality & reproducible).

### 2. Data Collection and Preparation
- [ ] Download datasets for reproduction.
- [ ] Data preprocessing: cleaning, standardizing, and splitting the dataset.

### 3. Model Replication
#### 3.1 Disease Predictor
##### 3.1.1 prostate Predictor
- [ ] Download original code or model parameters.
- [ ] Implement the Disease Predictor model.
- [ ] Train and test on the original literature dataset (if available).
- [ ] Evaluate the performance of the Predictor model using literature appendix materials.

##### 3.1.2 pancreat cancer Predictor
- [ ] Download original code or model parameters.
- [ ] Implement the Disease Predictor model.
- [ ] Train and test on the original literature dataset (if available).
- [ ] Evaluate the performance of the Predictor model using literature appendix materials.

##### 3.1.3 conmmon traits Predictor
- [ ] Download original code or model parameters.
- [ ] Implement the Disease Predictor model.
- [ ] Train and test on the original literature dataset (if available).
- [ ] Evaluate the performance of the Predictor model using literature appendix materials.

##### 3.1.4 fetal alcohol spectrum disorder Predictor
- [ ] Download original code or model parameters.
- [ ] Implement the Disease Predictor model.
- [ ] Train and test on the original literature dataset (if available).
- [ ] Evaluate the performance of the Predictor model using literature appendix materials.

#### 3.2 Tissue Predictor
- [ ] Download original code or model parameters.
- [ ] Implement the Tissue Predictor model.
- [ ] Train and test on the original literature dataset (if available).
- [ ] Evaluate the performance of the Predictor model using literature appendix materials.

### 4. Application to Our Data
- [ ] Application 3.1.1
- [ ] Application 3.1.2
- [ ] Application 3.1.3
- [ ] Application 3.1.4
- [ ] Application 3.2
- [ ] Compare differences between different models and our model.

## Timeline demo


| Phase                     | Task                                                                      | Deadline   |
|---------------------------|---------------------------------------------------------------------------|------------|
| 1. Literature Review      | Read papers and select suitable ones                                      |   |
| 2. Data Collection        | Download datasets for reproduction                                        |  |
|                           | Data preprocessing: cleaning, standardizing, and splitting the dataset    |       |
| 3. Model Replication      | 3.1 Disease Predictor                                                   |          |
|                           |   3.1.1 Prostate Predictor                                              |        |
|                           |     - [ ] Download original code or model parameters                    |     |
|                           |     - [ ] Implement the Disease Predictor model                          |      |
|                           |     - [ ] Train and test on the original literature dataset (if available)|       |
|                           |   3.1.2 Pancreatic Cancer Predictor                                    |            |
|                           |     - [ ] Download original code or model parameters                    |  |
|                           |     - [ ] Implement the Disease Predictor model                          |      |
|                           |     - [ ] Train and test on the original literature dataset (if available)|       |
|                           |     - [ ] Evaluate the performance of the Predictor model using literature appendix materials |  |
|                           |   3.1.3 Common Traits Predictor                                        |            |
|                           |     - [ ] Download original code or model parameters                    |      |
|                           |     - [ ] Implement the Disease Predictor model                          |      |
|                           |     - [ ] Train and test on the original literature dataset (if available)|      |
|                           |     - [ ] Evaluate the performance of the Predictor model using literature appendix materials |  |
|                           |   3.1.4 Fetal Alcohol Spectrum Disorder Predictor                      |           |
|                           |     - [ ] Download original code or model parameters                    |      |
|                           |     - [ ] Implement the Disease Predictor model                          |      |
|                           |     - [ ] Train and test on the original literature dataset (if available)|      |
|                           |     - [ ] Evaluate the performance of the Predictor model using literature appendix materials |  |
|                           | 3.2 Tissue Predictor                                                    |            |
|                           |   - [ ] Download original code or model parameters                      |      |
|                           |   - [ ] Implement the Tissue Predictor model                             |    |
|                           |   - [ ] Train and test on the original literature dataset (if available) | 1    |
|                           |   - [ ] Evaluate the performance of the Predictor model using literature appendix materials | |
| 4. Application to Our Data | - [ ] Application 3.1.1                                                |     |
|                           | - [ ] Application 3.1.2                                                |         |
|                           | - [ ] Application 3.1.3                                                |        |
|                           | - [ ] Application 3.1.4                                                |         |
|                           | - [ ] Application 3.2                                                  |      |
|                           | - [ ] Compare differences between different models and our model       |       |


## GEO dataset list
| Disease | Used Datasets | External Datasets | Train Datasets |Test Datasets | Validation Datasets | Priority(1-3) | Filename |
|---------|--------------|--------------|---------|--------------|--------------|---|---|
| Alzheimer's disease                        | [GSE43414](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43414), [GSE59685](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59685), [GSE72778](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72778), [GSE66351](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66351), [GSE80970](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80970), [GSE79144](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE79144), [GSE53740](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53740) | [GSE208623](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208623), [GSE153712](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153712), [GSE125895](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE125895)(450k), [GSE45776](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45776)(27k), [GSE57361](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57361)(450k and 2000) |GSE66351|GSE80970|GSE208623| 3| commontrait_AD |
| Asthma                                      | [GSE85566](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85566), [GSE104471](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE104471), [GSE52074](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52074), [GSE56553](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56553) |  [GSE210843](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE210843)(450K and others), [GSE157651](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157651) (450K), [GSE85228](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85228)(Other platform), [GSE40736](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40736)(450K)                                                                                                                 |GSE85566 GSE104471 |GSE85566 GSE104471  |GSE52074 |3|commontrait_Asthma|
| Autism spectrum disorder                   | [GSE50759](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50759) (450K)(ectodermal cell)                                | [GSE164563](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE164563)(450K)(Whole blood), [GSE99935](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE99935)(Other platform), [GSE131706](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131706)(450K)(Whole blood), [GSE109905](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109905)(450K)(Whole blood), [GSE119981](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE119981)(Hiseq 2000 and other), [GSE108785](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108785)(450K)(Whole blood), [GSE67615](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67615)(Hiseq 2000), [GSE109042](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109042)(450K / FASD)(epithelial cells), [GSE80261](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80261)(450K / FASD)(epithelial cells), [GSE53924](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53924)(450K)(frontal cortex), [GSE53162](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53162)(450K / post mortem)(frontal cortex), [GSE27044](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27044)(27K / Seems uncurated), [GSE38608](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38608)(27K), [GSE21395](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21395)(Other platform / Unsure about quality)                                         |GSE109905 GSE164563 | GSE109905 GSE164563|GSE108785 GSE109042|3|commontrait_ASD|
| Crohn's disease                            | [GSE87640](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87640)(450K)(Cell), [GSE87648](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87648)(450K)(Whole blood), [GSE32148](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32148)(450K)(Whole blood) | [GSE105798](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE105798)(450K)(tissue), [GSE138311](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138311)(850K), [GSE81961](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81961)(450K)(Whole blood)                                      |GSE87648 |GSE81961 | GSE32148|3|commontrait_Crohn|
| Down syndrome                              | [GSE63347](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63347)(450K)(Brain), [GSE73747](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73747)(450K)(Brain), [GSE52588](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52588)(450K)(Whole blood), [GSE64495](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64495)(450K/syndrome X)(Whole blood) | [GSE174555](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE174555)(450K)(Whole blood), [GSE160637](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160637)(Other platform), [GSE107211](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE107211)(450K)(Whole blood), [GSE74519](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74519)(450K)(Brain), [GSE74486](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74486)(450K)(Brain),[GSE50586](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50586)(450K)(epithelial cell), [GSE20872](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20872)(27K / With leukemia)(bone marrow), [GSE25395](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE25395)(27K)(T cell)         | GSE52588| GSE174555|GSE107211 |3|commontrait_Down|
| Type 2 diabetes                            | [GSE58280](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58280)(450K pre and post exercise)(Vastus Lateralis), [GSE62003](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62003) (450K)(Whole blood) | [GSE166652](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166652)(450K)(Myoblast), [GSE186766](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE186766)(Other indication), [GSE166787](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166787)(450K)(Myoblast), [GSE139157](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139157)(Hiseq 2500), [GSE94729](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE94729)(Hiseq 2500), [GSE121820](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121820)(Other platform), [GSE103657](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103657)(450K)(Whole blood), [GSE65057](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65057)(450k)(liver tissue), [GSE57484](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57484)(27K), [GSE38291](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38291)(27K), [GSE21232](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21232)(27K), [GSE33032](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE33032)(Other platform), [GSE17727](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17727)(Other platform)                                         |  | | |3|   
| Parkinson's disease                        | [GSE57360](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57360)(450K)(other disease), [GSE111223](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111223)(450K)(saliva), [GSE111629](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111629)(450K)(Whole blood and saliva), [GSE72774](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72774)(450K)(Whole blood), [GSE72776](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72776)(450K)(Whole blood) | [GSE195834](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195834)(EPIC)(Brain), [GSE122244](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122244)(850K), [GSE165083](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165083)(450K and other)(Whole blood)                                         | | | |3|commontrait_Parkinson|
| Multiple sclerosis                         | [GSE40360](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40360)(450K)(frontal lobe), [GSE106648](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE106648)(450K)(Whole blood), [GSE88824](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE88824)(450K)(Whole blood), [GSE43976](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43976)(450K)(Whole blood and Monocytes) | [GSE189258](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189258)(450K)(T cell) , [GSE235106](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235106)(Other platform), [GSE166207](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166207)(Methylation Epic), [GSE173787](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE173787)(Novaseq 6K), [GSE149562](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE149562)(Other platform), [GSE130030](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130030)(450K)(T cell), [GSE130029](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130029)(450K)(T cell), [GSE101658](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE101658)(450K)(hippocampus)                                        | | | |3|commontrait_Multisclerosis|
| Stroke                                      | [GSE66500](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66500)(450K)(carotid plaque), [GSE69138](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69138)(450K)(Whole blood)                 | [GSE203399](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE203399)(450K)(Whole blood)                                         |  | | |3|   
| Psoriasis                                  | [GSE63315](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63315) (450K)(epidermal cell), [GSE73894](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73894) (450K)(epidermal cell), [GSE115797](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE115797) (450K) (epidermal cell)| [GSE236695](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE236695)(Epic), [GSE236694](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE236694)(Epic / Multiple groups), [GSE200376](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200376)(850K / Multiple groups), [GSE186713](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE186713)(850K), [GSE184500](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE184500)(EPIC), [GSE151278](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151278)(450K)(Whole blood)(all disease), [GSE103038](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103038)(Hiseq 1500), [GSE31835](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31835)(27k)                                                                     | | | |3|
| Rheumatoid arthritis                       | [GSE111942](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111942), [GSE42861](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42861)                 | [GSE228104](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228104)(850K / post treatment), [GSE176168](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE176168)(850K / post treatment), [GSE186179](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE186179)(Hiseq 2500), [GSE188509](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE188509)(Hiseq 2500 & 3000 / Post Methotrexate), [GSE175364](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE175364)(450K), [GSE164468](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE164468)(EPIC), [GSE138747](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138747)(4K EPIC / Used for ML prediction), [GSE121192](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121192)(450K), [GSE135770](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE135770)(2500 & 3000), [GSE137634](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137634)(EPIC), [GSE137594](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137594)(EPIC), [GSE137593](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137593)(EPIC), [GSE131989](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131989)(450K), [GSE71841](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71841)(450K), [GSE87095](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87095)(450K), [GSE80071](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80071)(450K), [GSE46650](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46650)(450K), [GSE19033](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE19033)(Other platform / Multiple conditions)| | | |3|   
| Schizophrenia                              | [GSE61431](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61431)(450K)(Brain), [GSE89702](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89702)(450K)(Brain), [GSE74193](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74193)(450K)(Cortex), [GSE61107](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61107), [GSE61380](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61380)(450K)(Cortex), [GSE89705](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89705)(450K)(Striatum), [GSE89706](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89706)(450K)(Striatum), [GSE84727](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84727)(450K)(Whole blood), [GSE116378](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116378)(450K)(Whole blood), [GSE116379](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116379)(450K)(Whole blood) | [GSE152027](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152027),[GSE152026](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152026)(EPIC),[GSE147221](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147221)(450K),[GSE144910](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE144910)(EPIC),[GSE108066](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108066)(250K and other),[GSE112525](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112525)(250K and other and bipolar disorder),[GSE50960](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50960)(Other platform),[GSE61862](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61862)(Interesting but other platform),[GSE38873](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38873)(27K),[GSE41169](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41169)(450K),[GSE41037](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41037)(27K) |   | | |3|   
| Systemic insulin resistance                | [GSE76394](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76394), [GSE76285](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76285), [GSE76398](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76398) |                                                                                                                   |  | | |2|   
| Ulcerative colitis                         | [GSE87640](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87640), [GSE87648](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87648), [GSE32148](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32148) | [GSE81211](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81211),[GSE185061](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185061)(EPIC),[GSE110534](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110534)(Other platform),[GSE87650](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87650)(450K),[GSE42921](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42921)(450K and Crohn),[GSE56298](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56298)(Platform unclear),[GSE32146](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32146)(450K and Crohn),[GSE32149](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32149)(450K and Crohn),[GSE27899](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27899)(27K)                                         |  | | |2|
| Panic disorder                              | [GSE102468](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102468)                               | [GSE201016](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE201016)                                         |  | | |2|
| Respiratory allergy                        | [GSE110128](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110128), [GSE73745](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73745)                 |          | | | |2|      
| Graves' disease                            | [GSE71955](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71955)                                 |                                                                                                                   | | | | 2||                                                                                            |
| Silver Russell syndrome       | [GSE55491](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55491), [GSE104451](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE104451) | only one 850k array [GSE237503](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237503) |   | | |1|   
| Sjogren's syndrome            | [GSE75679](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75679) | [GSE146116](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146116)(850K) |   | | |1|  
| Preeclampsia                  | [GSE44667](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE44667), [GSE100197](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE100197), [GSE103253](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103253), [GSE57767](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57767), [GSE73375](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73375), [GSE75196](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75196) | [GSE245779](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245779), [GSE154378](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154378)(4k / Pregnancy Adverse Outcomes), [GSE98224](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98224)(450K), [GSE73377](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73377)(450K), [GSE59274](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59274)(27K), [GSE49343](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49343)(450K / Overlapping trisomy 16 and Pre eclampsia), [GSE44712](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE44712)(450K) |  | | |1|
| Kabuki syndrome               | [GSE97362](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97362), [GSE116300](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116300) | [GSE218186](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218186) [GSE97362](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97362)  [GSE116300](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116300) |GSE97362 | GSE116300|GSE218186 |1|  commontrait_Kabuki_Syndrome |
| Spina bifida                    | [GSE69502](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69502)                  | [GSE81846](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81846) |  | | |1|   
| Systemic lupus erythematosus    | [GSE59250](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59250), [GSE110607](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110607), [GSE80553](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80553) | [GSE76056](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76056) , [GSE207861](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE207861)(EPIC), [GSE179801](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE179801)(EPIC), [GSE161476](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161476)(EPIC), [GSE96879](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96879)(450K), [GSE118255](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118255)(2500 / ), [GSE118144](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118144)(EPIC), [GSE57869](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57869)(27K), [GSE82221](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE82221)(450K), [GSE27895](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27895)(27K) |  | | |1|   
| Systemic sclerosis              | [GSE117929](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117929)                | [GSE196007](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196007)(EPIC), [GSE175379](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE175379)(EPIC), [GSE150592](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE150592)(250K), [GSE117931](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117931)(450K)|                                                           |  | | |1|   
| Childhood asthma                           | [GSE65163](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65163), [GSE104087](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE104087), [GSE109446](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109446), [GSE40576](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40576) |                                                                                                                   | | | |1|
| Nephrogenic rest                           | [GSE59157](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59157)                                 |                                                                                                                   |  | | |1|
| Intellectual disability and congenital anomalies | [GSE89353](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89353)                               |                                                                                                                   | | | |1|
| Huntington's disease                       | [GSE72778](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72778)(450K)(Brain)                                 | [GSE147004](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147004)(450K)(Whole blood)| | | |1|
